Skip to main content

Teranode Design Suite 2, GenBank release 144.0, HapMap data release 12, IBM Solution for Compliance in a Regulated Environment (SCORE)

Premium

Teranode has released three new products: Teranode Design Suite 2, a “closed-loop” R&D platform for integrating modeling into existing informatics infrastructures; Teranode Model Server, which provides a single repository for managing design through protocol development and experimentation to evaluation; and the Teranode Accelerator Development Kit, which contains an application programming interface, a library of existing integrations, and documentation.


GenBank release 144.0 is now available via ftp from the National Center for Biotechnology Information at ftp://ftp.ncbi.nih.gov/. The release contains 43,194,602,655 base pairs and 38,941,263 entries, up by 1,386,557,002 base pairs and by 1,597,326 sequence records (non-WGS) and 2,742,978,532 base pairs and by 857,503 sequence records (WGS) from the August 143.0 release. Uncompressed, the 144.0 flat files require about 147 GB for the sequence files only. The ASN.1 version requires around 128 GB.


HapMap data release 12 is now available from the HapMap Data Coordination Center at Cold Spring Harbor Laboratory at http://www.hapmap.org. The release contains 752,208 genotype sets from the 90 CEPH-panel samples, totaling 67,698,720 genotypes, according to the organization.


IBM Healthcare and Life Sciences said they have launched the IBM Solution for Compliance in a Regulated Environment (SCORE). The technology is designed as a regulatory compliance system to help pharmaceutical, biotechnology, and medical device companies comply with regulatory mandates for R&D, manufacturing, and sales and marketing processes.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.